Latest News

Heparin derivative suppresses neuroblastoma tumor growth

A new strategy for treating neuroblastoma using a modified version of heparin, a century-old injectable drug that thins the blood to prevent clots from forming, has been discovered by researchers. The study, conducted in mice, found that when heparin is altered to remove its blood-thinning properties, it can suppress and shrink neuroblastoma tumors without causing severe bleeding.
View full story

Post your comment.


  • Molecular trigger for cerebral cavernous malformation identified

  • Researchers urge caution in prescribing commonly used drug to treat ADHD

  • Even the elderly can recover from a severe traumatic brain injury

  • Instrument to measure brand embarrassment developed by economists

  • White matter damage caused by 'skunk-like' cannabis, study shows

  • Cognitive behavior therapy can help overcome fear of the dentist

  • How can I tell if they're lying?

  • Amblyopia, not strabismus, identified as key contributor to slow reading in school-age children

  • Visual stress could be a symptom of Chronic Fatigue Syndrome, research suggests

  • Lower availability of omega-3 fatty acids in the body associated with bipolar disorder